MetaADEDB 2.0 @ LMMD
Methotrimeprazine
(VRQVVMDWGGWHTJ-UHFFFAOYSA-N)
Structure
SMILES
COc1ccc2c(c1)N(CC(CN(C)C)C)c1c(S2)cccc1
Molecular Formula:
C19H24N2OS
Molecular Weight:
328.472
Log P:
4.5606
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
0
TPSA:
41.01
CAS Number(s):
851-68-3
Synonym(s)
1.
Methotrimeprazine
External Link(s)
PubChem Compound3916
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 2Canada Vigilance
2AgitationCanada Vigilance: 4Canada Vigilance
3AgranulocytosisCanada Vigilance: 4Canada Vigilance
4AkathisiaCanada Vigilance: 19Canada Vigilance
5AnuriaCanada Vigilance: 1Canada Vigilance
6AstheniaCanada Vigilance: 2Canada Vigilance
7CellulitisCanada Vigilance: 1Canada Vigilance
8Completed SuicideCanada Vigilance: 2Canada Vigilance
9ConstipationCanada Vigilance: 19Canada Vigilance
10CyanosisCanada Vigilance: 1Canada Vigilance
11DermatitisCanada Vigilance: 1Canada Vigilance
12DizzinessCanada Vigilance: 20Canada Vigilance
13DysarthriaCanada Vigilance: 4Canada Vigilance
14DysphoniaCanada Vigilance: 1Canada Vigilance
15DystoniaCanada Vigilance: 4Canada Vigilance
16EpistaxisCanada Vigilance: 1Canada Vigilance
17Erectile dysfunctionCanada Vigilance: 1Canada Vigilance
18ErythemaCanada Vigilance: 1Canada Vigilance
19FlushingCanada Vigilance: 1Canada Vigilance
20HeadacheCanada Vigilance: 2Canada Vigilance
21HypersensitivityCanada Vigilance: 1Canada Vigilance
22HypotensionCanada Vigilance: 21Canada Vigilance
23LeukopeniaCanada Vigilance: 4Canada Vigilance
24Lip swellingCanada Vigilance: 1Canada Vigilance
25Muscle RigidityCanada Vigilance: 12Canada Vigilance
26NauseaCanada Vigilance: 2Canada Vigilance
27NeutropeniaCanada Vigilance: 1Canada Vigilance
28Oculogyric crisisCanada Vigilance: 5Canada Vigilance
29PallorCanada Vigilance: 3Canada Vigilance
30PruritusCanada Vigilance: 1Canada Vigilance
31Rash erythematousCanada Vigilance: 2Canada Vigilance
32RestlessnessCanada Vigilance: 1Canada Vigilance
33Sedation complicationCanada Vigilance: 1Canada Vigilance
34Skin reactionCanada Vigilance: 1Canada Vigilance
35SomnolenceCanada Vigilance: 62Canada Vigilance
36StuporCanada Vigilance: 1Canada Vigilance
37SyncopeCanada Vigilance: 7Canada Vigilance
38TachycardiaCanada Vigilance: 3Canada Vigilance
39Tardive DyskinesiaCanada Vigilance: 1Canada Vigilance
40TremorCanada Vigilance: 28Canada Vigilance
41TrismusCanada Vigilance: 1Canada Vigilance
42Urinary IncontinenceCanada Vigilance: 1Canada Vigilance
43Urinary RetentionCanada Vigilance: 2Canada Vigilance
44VertigoCanada Vigilance: 4Canada Vigilance
45VomitingCanada Vigilance: 2Canada Vigilance
46jaundiceCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.